Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,068.80down ₹28.70 (2.62%)BSE ₹1,069.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,097.50.
30 Oct: open ₹1,050.00, high ₹1,076.90, low ₹972.00
52-week range of traded prices to 30 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,851 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.47%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,77,98551.0% delivered
Strides Pharma Science results
118 filed, newest first. Page 3 of 3.
Jul 2008
22 Jul · Results
Standalone Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 28046.21 lacs for half year ending on 30-JUN-2008 against Rs. 21129.3 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. (7200.91) lacs for the half year ending on 30-JUN-2008 against Rs. 1794 lacs for the half year ending on 30-JUN-2007.22 Jul · Results
Consolidated Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 46233.1 lacs for half year ending on 30-JUN-2008 against Rs. 34142.3 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 375.09 lacs for the half year ending on 30-JUN-2008 against Rs. 1765.5 lacs for the half year ending on 30-JUN-2007.22 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 16077.45 lacs for quarter ending on 30-JUN-2008 against Rs. 10522.1 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. (5596.11) lacs for the quarter ending on 30-JUN-2008 against Rs. 1018.1 lacs for the quarter ending on 30-JUN-2007.22 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 25535.33 lacs for quarter ending on 30-JUN-2008 against Rs. 17989.9 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. (4884.26) lacs for the quarter ending on 30-JUN-2008 against Rs. 1158.3 lacs for the quarter ending on 30-JUN-2007.
Jun 2008
19 Jun · Results
Based on the Scrutinizer's Report dated June 18, 2008, the special resolutions seeking approval of the shareholders through Postal Ballot concerning the following matters have been carried out with requisite majority. (1) Inter-Corporate investment under section section 372A of the Companies Act 1956 for investment of upto Rs. 60 Crores in Onco Therapies Limited. (2) Inter-Corporate investment under section 372A of the Companies Act, 1956 for investment of upto USD 800,000 in Akorn Strides LLC, USA. (3) Strides Arcolab Employee Stock Option Plan- 2008. (4) Extension of Strides Arcolab Employee Stock Option Plan - 2008 to employees of Subsidiary Companies. (5) Amendment to Strides Arcolab Employee Stock Option Plan 2006.
Apr 2008
28 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 11968.8 lacs for quarter ending on 31-MAR-2008 against Rs. 10607.3 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. (1604.8) lacs for the quarter ending on 31-MAR-2008 against Rs. 776 lacs for the quarter ending on 31-MAR-2007.28 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 20697.8 lacs for quarter ending on 31-MAR-2008 against Rs. 16152.4 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5259.4 lacs for the quarter ending on 31-MAR-2008 against Rs. 607.2 lacs for the quarter ending on 31-MAR-2007.
Mar 2008
7 Mar · Results
Standalone Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 39291.5 lacs for year ending on 31-DEC-2007 against Rs. 45508.8 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. (11521.4) lacs for the year ending on 31-DEC-2007 against Rs. 3618.41 lacs for the year ending on 31-DEC-2006.7 Mar · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 7575.8 lacs for quarter ending on 31-DEC-2007 against Rs. 12920.8 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. (13340.4) lacs for the quarter ending on 31-DEC-2007 against Rs. 1296.91 lacs for the quarter ending on 31-DEC-2006.7 Mar · Results
Consolidated Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 72561.2 lacs for year ending on 31-DEC-2007 against Rs. 74298.4 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. (5012.1) lacs for the year ending on 31-DEC-2007 against Rs. 4022.9 lacs for the year ending on 31-DEC-2006.
Jan 2008
24 Jan · Results
The Company will declare and publish the Audited Financial Results for the financial year ended December 31, 2007 before March 31, 2008. In view of the same, the Company would not be declaring and publishing the Unaudited Financial Results for the last quarter ended December 31, 2007 during the month of January, 2008
Oct 2007
30 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 20429.3 lacs for quarter ending on 30-SEP-2007 against Rs. 17781.8 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. (903.3) lacs for the quarter ending on 30-SEP-2007 against Rs. 1302.2 lacs for the quarter ending on 30-SEP-2006.30 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 10586.4 lacs for quarter ending on 30-SEP-2007 against Rs. 11782 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 24.9 lacs for the quarter ending on 30-SEP-2007 against Rs. 893.3 lacs for the quarter ending on 30-SEP-2006.
Jul 2007
27 Jul · Results
Consolidated Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 34142.3 lacs for half year ending on 30-JUN-2007 against Rs. 29995.5 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 1765.5 lacs for the half year ending on 30-JUN-2007 against Rs. 1446.4 lacs for the half year ending on 30-JUN-2006.27 Jul · Results
Standalone Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 21129.3 lacs for half year ending on 30-JUN-2007 against Rs. 20806 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 1794 lacs for the half year ending on 30-JUN-2007 against Rs. 1428.2 lacs for the half year ending on 30-JUN-2006.27 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 17989.9 lacs for quarter ending on 30-JUN-2007 against Rs. 16729.2 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 1158.3 lacs for the quarter ending on 30-JUN-2007 against Rs. 549.5 lacs for the quarter ending on 30-JUN-2006.27 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 10522.1 lacs for quarter ending on 30-JUN-2007 against Rs. 10014.3 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 1018.1 lacs for the quarter ending on 30-JUN-2007 against Rs. 487.8 lacs for the quarter ending on 30-JUN-2006.
Apr 2007
23 Apr · Results
Based on the Scrutinizer's Report dated April 23, 2007, the Special resolution seeking confirmation of the shareholders under Section 372A of the Companies Act, 1956, for the Corporate Guarantee issued by the Company for an amount of USD 3.0 Million in favour of State Bank of India, New York Branch for the facilities availed by Strides Inc., a subsidiary of the Company in USA, was carried out by requisite majority through Postal Ballot